Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

Palbociclib generally maintains or improves quality of life in advanced breast cancer patients.

UK dermatologists commonly use corticosteroids and minoxidil to treat hair loss conditions.

"Clinically proven" claims require strict testing and adherence to guidelines for trust and authenticity.

Drug repositioning is a promising way to quickly develop new treatments, especially for rare diseases.

Upadacitinib helps most people with alopecia regrow hair quickly and is generally safe.

Women experience more side effects and have worse blood pressure control from hypertension treatments than men, despite using different medications.

Prurigo nodularis is hard to diagnose and treat, but new biologics offer hope for better management.

New and repurposed treatments are improving outcomes in dermatology.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

New treatments are needed for non-scarring alopecia due to current limitations.

More effective treatments are needed for alopecia areata, hidradenitis suppurativa, and vitiligo.

GLP-1 receptor agonists help with weight loss but need to be combined with other treatments for best results.

Rivaroxaban and fondaparinux are effective for certain blood conditions, and hydroxyurea helps in sickle cell disease.

The hybrid ensemble model improves scalp disease detection accuracy and consistency.

Transforming skin disease treatment requires new strategies, better drug models, and patient-focused research.

Chinese patients with alopecia areata value JAK inhibitors but worry about side effects and relapse, highlighting the need for education and support.

Hair thinning is a common but generally mild and reversible side effect of teriflunomide in multiple sclerosis patients.

64 drugs can cause hair loss, needing better monitoring and updated labels.

Corticosteroids are the most common treatment for alopecia areata, but many patients need better options.

Sebamed® shampoo effectively reduces hair loss and promotes hair growth.

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.

Baricitinib is widely used for several conditions, especially COVID-19, but its safety and effectiveness are still being evaluated.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Aumolertinib effectively controls lung cancer and improves quality of life.

Current treatments for severe alopecia areata are unsatisfactory, highlighting the need for better options.

Dupilumab helps children with alopecia areata regrow hair safely.

Finasteride can cause long-term side effects like sexual dysfunction and depression.

Avacopan is generally safe, with some minor side effects like nausea and fatigue.

Alopecia areata severely impacts quality of life, causing anxiety, depression, and work impairment.